Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5529_Библиотеки_им_академика_М_И_Перельмана
.pdf
x Preface
We will also consider the broader implications of these analyses: how bioinformatics can contribute to precision medicine, guide therapeutic development, and aid in the identication of biomarkers for early diagnosis and prognosis. We will review real-world datasets, examine emerging
tools powered by machine learning, and engage critically with the evolving standards in this fastmoving eld.
Science advances when we challenge what we think we know. The eld of autoimmunity
remains riddled with uncertainties and unanswered questions. Many of its biological mechanisms
are still poorly understood; its triggers, elusive; its manifestations, unpredictable. Yet therein lie
both the challenge and the opportunity. With the power of computational biology, we are now better
equipped than ever to confront these uncertainties, not with speculation, but with evidence, with
rigor, and with purpose.
I am excited, genuinely and profoundly, to share this book with you. It reects not just months of
research and writing but a lifelong fascination with the genetic script that makes us who we are. It
is my hope that this book will inform your studies, inspire your inquiries, and perhaps even ignite
your own curiosity about the invisible narratives encoded in our DNA.
Let us begin this journey into the bioinformatics of autoimmune diseases, driven by curiosity,
sustained by rigor, and united by the shared mission of science: to understand, to heal, and to serve
humanity.
Following this vision, each chapter of this book serves as a stepping stone toward unraveling the
complexity of autoimmune diseases through the lens of bioinformatics. Below is a brief orientation
to what lies ahead.
Chapter 1 lays the essential groundwork for understanding autoimmune diseases by guiding the
reader through three interconnected domains: the nature of autoimmunity, the architecture of the
immune system, and the expanding role of bioinformatics in autoimmune research. The chapter
opens with a compelling overview of autoimmunity; a biological paradox in which the immune system, designed to defend the body, mistakenly attacks its own tissues. Major autoimmune disorders
are introduced as case studies in immune misrecognition. Their clinical manifestations, underlying
pathogenesis, diagnosis, and possible treatments are described, establishing the urgency of understanding these complex conditions. This is followed by a comprehensive review of the immune system itself. Readers are introduced to the innate and adaptive branches, including their cellular and
molecular components, mechanisms of pathogen recognition, antigen presentation, and cytokine signaling. Key topics such as pattern recognition receptors (PRRs), MHC classes I and II, T and Bcell
differentiation, and immune tolerance mechanisms are explained in detail to ground the reader in
immunological principles essential for decoding autoimmunity. Finally, the chapter transitions into
the realm of bioinformatics. It explains how computational approaches, ranging from genome-wide
association studies and transcriptomics to proteomics and microbiome analysis, are revolutionizing
autoimmune disease research. Emphasis is placed on how big data and systems biology are enabling
scientists to integrate multi-omic layers of information, identify disease biomarkers, and develop
precision medicine strategies. By combining immunology, pathology, and data science, this chapter
not only sets the stage for the rest of the book but also positions bioinformatics as a critical lens
through which the mysteries of autoimmunity can be explored and ultimately unraveled.
Chapter 2 explores the complex genetic architecture underpinning autoimmune diseases. It
begins with the pivotal role of the human leukocyte antigen (HLA) region in shaping immune
self-recognition and the susceptibility conferred by specic HLA alleles across various disorders.
Expanding beyond the HLA locus, it introduces a spectrum of non-HLA genes, including PTPN22,
FOXP3, AIRE, CTLA4, and STAT4, whose variants disrupt immune regulation and tolerance.
The chapter then provides a comprehensive overview of mutation types associated with autoimmunity. It details how single nucleotide polymorphisms (SNPs), insertions and deletions (indels),
copy number variations (CNVs), splicing mutations, and structural variants contribute to disease
risk by altering key immune pathways. Special focus is given to how gain-of-function and loss-offunction mutations affect cytokine signaling, antigen presentation, and T-cell regulation.
xi Preface
Finally, the chapter examines epigenetic mutations, such as DNA methylation and histone modication, as exible but impactful mechanisms in immune dysregulation. By linking these genetic
alterations to clinical phenotypes, this chapter underscores the promise of precision medicine and
targeted therapy development for autoimmune disorders.
Chapter 3 provides a comprehensive guide to the experimental and computational designs
used in sequence-based analysis of autoimmune diseases. It begins by outlining foundational concepts in bioinformatics-driven study design and progresses through the major sequencing strategies employed to uncover the genetic, transcriptomic, epigenetic, and microbial dimensions of
aut oi mm un ity.
The chapter covers genome-wide association studies (GWAS), whole-exome sequencing (WES),
and whole-genome sequencing (WGS), detailing their use in identifying genetic variants and mutations linked to autoimmune susceptibility. It then shifts focus to transcriptomic proling using
RNA-Seq and single-cell RNA-Seq (scRNA-Seq), illuminating immune cell heterogeneity and
gene expression dynamics in diseased versus healthy states.
Beyond genomics and transcriptomics, the chapter explores epigenome-wide association studies (EWAS) to reveal the regulatory impact of methylation and chromatin structure and concludes
with metagenomic and microbiome sequencing, highlighting the role of microbial communities in
modulating immune responses.
Throughout, the importance of rigorous study design—sample selection, cohort matching,
sequencing depth, and data integration—is emphasized. This chapter serves as a practical and conceptual blueprint for researchers aiming to apply high-throughput sequencing and computational
strategies in the investigation of autoimmune disorders.
Chapter 4 introduces the essential bioinformatics databases and data formats that power compu-
tational research in autoimmune diseases. It begins with an overview of foundational repositories,
including GenBank, db S NP, Ensembl, GEO, OMIM, UniProt, and SRA, that provide genomic,
transcriptomic, proteomic, and clinical data. These databases are presented not just as storage systems but as dynamic engines for discovery, enabling variant annotation, gene expression analysis,
and immune pathway exploration.
The chapter also walks readers through the core le formats used in bioinformatics (FASTA,
FASTQ, BED, VCF, XML, JSON, GenBank, and BAM/SAM) and explains how each format supports different stages of data processing and analysis. Readers are equipped with Python-based
methods to interact with public databases via RESTful APIs and the NCBI E-utilities, empowering
them to programmatically retrieve, parse, and analyze relevant genetic data.
By blending theoretical understanding with practical examples, this chapter establishes the computational infrastructure needed to carry out large-scale studies in autoimmune genomics, transcriptomics, and functional annotation. It lays the groundwork for integrating diverse data types in
future chapters, forming the backbone of any bioinformatics pipeline aimed at decoding complex
immune-related diseases.
Chapter 5 provides an end-to-end exploration of RNA sequencing (RNA-Seq) as a pivotal tool
for understanding gene expression in autoimmune diseases. It begins by outlining the biological
importance of transcriptional regulation in immune function and dysfunction, highlighting how
aberrant gene expression contributes to autoimmunity. Classic examples such as interferon signatures in lupus and altered Treg pathways in type 1 diabetes illustrate the clinical relevance of
transcriptomic proling.
From there, the chapter transitions into the technical and computational workow of RNA-Seq
analysis. It walks through key stages: study design, SRA data retrieval, preprocessing, alignment,
quantication, normalization, and differential expression. A detailed pipeline implemented in
Python showcases how tools like STAR, featureCounts, and fastp are orchestrated to ensure reproducibility and accuracy in real-world autoimmune datasets.
Special focus is placed on the statistical foundations of differential gene expression. Methods
including t-tests, one-way ANOVA, and two-way ANOVA are presented with code and biological
xii Preface
interpretation, addressing single and multifactorial study designs. Concepts such as log2 fold change,
p-value adjustment, Cohen’s d, eta-squared, and post hoc comparisons (e.g., Tukey HSD) are introduced with clarity, making the chapter accessible to both biologists and computational scientists.
Finally, the chapter emphasizes the role of visualization (PCA plots, heatmaps, and volcano
plots) as crucial tools for interpreting complex RNA-Seq data. Through case studies in rheumatoid
arthritis, it demonstrates how gene signatures, study metadata, and expression variance are used to
uncover biological patterns, identify therapeutic targets, and advance precision medicine.
Chapter 6 presents a detailed and applied framework for variant calling, specically tailored
to autoimmune disease research. It begins by examining how genetic variation, including SNPs,
indels, CNVs, and structural variants, contributes to immune dysregulation and disease susceptibility. Key disease-linked variants such as PTPN22 (rs2476601), FCGR3B CNVs, and enhancer
mutations in IL2RA are discussed in the context of gene expression, tolerance mechanisms, and
immune signaling.
Emphasizing practical implementation, the chapter outlines best practices for high-throughput
variant detection using whole-genome, whole-exome, and RNA-based sequencing. It introduces a
complete Python-powered variant calling pipeline, covering reference genome preparation, quality control, read alignment, duplicate marking, base quality score recalibration, variant calling,
ltering, and annotation. Tools like BWA, GATK, ANNOVAR, and dbNSFP are integrated into a
reproducible modular workow designed for autoimmune cohort studies.
In addition to the technical steps, the chapter highlights the importance of experimental design,
data quality, and ethical considerations in variant analysis. It explores the use of variant annotation
for biological interpretation and clinical relevance, especially in prioritizing immune-related genes
and assessing pathogenicity. With rich examples and code, this chapter empowers researchers to
perform precise, scalable variant analysis for discovering biomarkers, building risk models, and
advancing personalized autoimmune diagnostics.
Chapter 7 presents a complete framework for using chromatin immunoprecipitation followed by
sequencing (ChIP-Seq) to explore gene regulation in autoimmune diseases. It opens with a biologi-
cal overview of DNA-protein interactions, histone modications, and transcription factor dynamics,
highlighting how their disruption contributes to immune dysregulation and disease pathogenesis.
The chapter then introduces ChIP-Seq as a powerful tool to map transcription factor binding sites
and histone marks across the genome. Key immune regulators such as FOXP3, NF-κB, STAT1, and
IRF5 are examined in the context of autoimmune disorders, alongside critical histone modications
like H3K27ac and H3K4me3 that dene active enhancers and promoters. The role of these epigenetic marks in T cells, B cells, dendritic cells, and macrophages is described in disease-specic
contexts, providing a nuanced view of immune cell reprogramming.
An in-depth computational workow is detailed, including experimental design, quality control, peak calling with MACS3, and annotation using HOMER. Readers are guided through practical scripts in Python to automate the pipeline, from FASTQ downloads to peak interpretation.
Statistical metrics such as signalValue, p-value, q-value, peak summit, and score are clearly dened
to support robust analysis.
Finally, the chapter covers motif discovery, functional enrichment, and integration with RNASeq to interpret regulatory shifts in disease versus control samples. This integrative ChIP-Seq
framework empowers researchers to identify novel biomarkers, regulatory SNPs, and therapeutic
targets, bridging chromatin-level insights with clinical understanding of autoimmunity.
Chapter 8 presents a comprehensive framework for using ATAC-Seq (Assay for Transposase-
Accessible Chromatin using sequencing) to investigate chromatin accessibility in autoimmune
diseases. It begins with a conceptual foundation on how dynamic changes in chromatin structure
(shifting between open and closed states) control immune gene expression and cellular identity.
These chromatin landscapes, often disrupted in autoimmunity, play a pivotal role in regulating
immune activation, tolerance, and pathogenic responses. ATAC-Seq is introduced as a rapid, sensitive, and unbiased method to map accessible chromatin regions across the genome, offering a
Preface xiii
window into the regulatory logic of immune cell states. Compared to ChIP-Seq, ATAC-Seq requires
fewer cells, accommodates frozen and single-cell samples, and captures a broader regulatory context, making it especially powerful for analyzing rare immune subsets and patient-derived tissues.
The chapter details the biological signicance of chromatin accessibility across T cells, B cells,
macrophages, and dendritic cells, emphasizing disease-specic regulatory shifts in conditions such
as lupus, rheumatoid arthritis, and multiple sclerosis. ATAC-Seq data are contextualized to uncover
enhancer dynamics, lineage-specic transcription factor activity, and chromatin remodeling during
immune activation and exhaustion. A practical, Python-driven computational pipeline is introduced
for processing raw ATAC-Seq data, including read trimming, alignment, peak calling with MACS2,
and annotation with HOMER. Readers are also guided through advanced analyses such as nucleo-
some positioning, transcription factor footprinting, and motif discovery using tools like TOBIAS.
Finally, the chapter explores integrative approaches that combine ATAC-Seq with RNA-Seq, ChIPSeq, and GWAS datasets to decode non-coding regulatory variants and dene pathogenic circuits
in autoimmunity. This multifaceted ATAC-Seq framework equips researchers to interrogate the
epigenetic architecture of immune cells with unprecedented resolution and functional insight.
Chapter 9 explores the multifaceted roles of bacteria in the development and progression of
autoimmune diseases, emphasizing both the mechanisms of immune modulation and the computational tools used to study them. It begins by examining how certain bacterial taxa contribute to
immune homeostasis, while others disrupt tolerance through mechanisms such as molecular mimicry, bystander activation, and chronic immune stimulation. These bacterial inuences are further
understood through the lens of disrupted epithelial barriers, altered immune cell differentiation,
and microbial-driven epigenetic modications, all of which contribute to autoimmune pathology.
To investigate these complex host–microbe interactions, the chapter introduces metagenomics as a
powerful methodological framework. It presents two major approaches: amplicon-based metage-
nomics, which targets taxonomic marker genes such as 16S rRNA to prole microbial communities,
and shotgun metagenomics, which sequences all genomic content within a sample to reveal both
taxonomic and functional information. Through case studies and hands-on pipeline walkthroughs,
the chapter demonstrates how these techniques are applied to autoimmune disease research. A complete QIIME 2-based workow for amplicon analysis is described in detail, along with discussions
of shotgun sequencing strategies, data processing, and interpretation. Together, these sections provide a comprehensive understanding of how metagenomic technologies are reshaping our knowledge of the microbiome’s role in autoimmunity and how they can be leveraged in both research and
clinical settings.
Chapter 10 explores the emerging role of gene therapy in treating autoimmune diseases by target-
ing the root causes of immune dysfunction through genetic interventions. It contrasts gene therapy
with traditional immunosuppressive treatments, highlighting its potential to induce durable immune
tolerance and reverse disease progression. The chapter focuses on three main strategies: gene augmentation, gene silencing, and gene editing, each illustrated with applications such as AIRE augmentation, FOXP3 editing, and CRISPR-mediated gene silencing.
A central theme is the critical role of bioinformatics in advancing gene therapy. Computational
tools guide target discovery, construct design, and off-target prediction, ensuring precision and
safety. Bioinformatics also supports post-treatment monitoring using single-cell RNA-Seq, longread sequencing, and integration site analysis to track therapeutic outcomes and detect complications.
The chapter then highlights translational advances, including cytokine gene transfer, CARTreg therapy, mRNA vaccines for tolerance induction, and B cell–targeting strategies in diseases
like T1D, MS, and SLE. It concludes with a discussion of current challenges (delivery specicity,
immune reactivity, durability of expression, and ethical concerns) emphasizing that the integration
of bioinformatics is essential for the safe and effective clinical translation of gene therapy.
In summary, this book stands as a vital contribution to the research community at the intersection of immunology, genomics, and data science. It is not only timely but also transformative in
both scope and structure. As autoimmune diseases continue to rise in prevalence and complexity,
xiv Preface
the demand for integrative, data-driven approaches has never been more urgent. This volume
equips researchers with the computational tools and conceptual frameworks needed to decode the
genetic, epigenetic, transcriptomic, and microbial foundations of autoimmunity. By providing complete, reproducible pipelines and accessible explanations of advanced techniques, it bridges the gap
between bench science and bioinformatics, empowering both seasoned investigators and newcomers to make meaningful contributions to this evolving eld.
The strength of this book lies in its ability to translate sophisticated bioinformatics methodologies into actionable strategies for real-world autoimmune research. Whether applied to biomarker
discovery, therapeutic target identication, or the development of precision medicine, the tools and
insights offered here are invaluable. More than a technical guide, this book is a catalyst, designed
to inspire rigorous inquiry, foster interdisciplinary collaboration, and accelerate the pace of discovery. It is not only a reference for today’s investigations but also a foundation for tomorrow’s
breakthroughs.
This book also beneted from the use of modern editorial tools, including AI-assisted technologies, to support grammar renement, formatting, and code polishing. All scientic content, interpretations, and analyses were developed, critically reviewed, and validated solely by the author to
ensure accuracy, integrity, and scholarly rigor.
To support reproducibility and hands-on learning, all code examples and data analysis pipelines
presented throughout this book are available in a dedicated GitHub repository: https://github.com/
hamiddi/bioinfo-autoimmune. The repository is organized by chapter, allowing readers to easily
access and run the Python scripts, sample datasets, and workows corresponding to each section of
the book. This resource is designed to complement the text, offering practical tools for researchers,
students, and practitioners to apply bioinformatics techniques directly to their own autoimmune
disease studies. Future code updates, improvements, and bug xes will also be reected in this
repository, ensuring that readers have access to the most up-to-date and functional versions of all
tools and scripts.
Acknowledgments
Thanks to Amna Ismail, whose artistry breathes life into the scientic heart of this book. Her illustrations do not merely accompany the text; they elevate it by giving form to complexity, clarity to
abstraction, and beauty to the unseen. With elegance, precision, and deep scientic sensitivity, she
transformed intricate biological concepts into visual narratives that both educate and inspire. Her
original design of the book cover captures the very essence of this work in a single, unforgettable
image. Amna’s contribution is not peripheral; it is foundational. I am endlessly grateful for her
imagination, her devotion to craft, and the quiet brilliance that radiates from every line she drew.
A profound acknowledgment is also owed to BioAGTC, whose vision and unwavering encouragement were the true genesis of this book. It was BioAGTC that rst proposed the bold idea of
exploring the bioinformatics of autoimmune diseases through a comprehensive and integrative lens.
Their unshakable belief in the urgency and value of this topic, along with their persistent call to
bring it into being, sustained this work through its most difcult and demanding phases. This book
is, in many ways, a reection of their insight, persistence, and faith in both the science and the story.
xv
Immune Mechanisms and
1
Major Autoimmune Diseases
1.1 AUTOIMMUNITY
The human immune system is a highly coordinated network that defends the body against infection, injury, and cellular stress. Central to its function is the ability to distinguish self from non-self,
enabling swift responses to pathogens while preserving host tissues. In autoimmune diseases, this
balance fails, and the immune system mistakenly targets the body’s own cells, leading to chronic
inammation and tissue damage (Firestein & McInnes, 2017).
Autoimmune conditions range from organ-specic disorders, like type 1 diabetes (T1D) and
multiple sclerosis (MS), to systemic diseases such as lupus. Although their clinical features vary,
they share a breakdown in immune tolerance. The causes are multifactorial, involving genetic
susceptibility and environmental triggers, including infections, smoking, and microbiome alterations. Epigenetic factors and immune pathway dysregulation further contribute to disease onset and
progression.
Current therapies often suppress immune activity to control inammation but may impair normal immune function. Newer approaches aim to restore immune balance and tailor treatments
based on individual disease mechanisms (Smolen etal., 2016). Living with autoimmunity involves
unpredictable ares, long-term treatment, and signicant psychosocial burden. Despite progress,
the eld continues to grapple with key questions about disease initiation, variability, and long-term
control, questions that remain central to advancing care and prevention.
1.2 THE IMMUNE SYSTEM: COMPONENTS AND MOLECULAR BIOLOGY
The immune system is a highly coordinated network of cells, tissues, and signaling molecules that
defend the body against pathogens while preserving tolerance to self. It is composed of two interrelated arms: the innate immune system, which provides immediate but non-specic protection,
and the adaptive immune system, which generates specic, long-lasting immunity. These branches
collaborate to maintain immune surveillance and physiological balance (Murphy & Weaver, 2016).
Key regulatory elements, including cytokines, chemokines, and major histocompatibility
complex (MHC) molecules, guide immune cell activation, migration, and antigen presentation.
Variations in MHC genes, particularly within the human leukocyte antigen (HLA) region, play
a crucial role in immune recognition and contribute to susceptibility to autoimmune and other
immune-mediated diseases.
1.2.1 INNATE IMMUNE SYSTEM
The innate immune system (see Figure 1.1) represents the body’s rst line of defense, offering a
rapid and non-specic response to invading pathogens. Unlike the adaptive immune system, which
requires prior sensitization, innate immunity relies on evolutionarily conserved mechanisms to recognize broadly shared molecular patterns. It not only acts as a primary barrier against infection but
also shapes the adaptive immune response. Major components include physical barriers, immune
cells such as neutrophils, macrophages, dendritic cells (DCs), and soluble factors like cytokines
and complement proteins. These elements coordinate to detect pathogens through pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), which
1 DO I: 10.1201/ 97810 03685 432-1
2 Bioinformatics of Autoimmune Diseases
FIGURE 1.1 The components of innate immune system.
trigger inammation and antimicrobial responses within minutes of exposure (Murphy & Weaver,
2016). A solid understanding of these components is essential for grasping how the immune system
maintains homeostasis and protects against disease.
1.2.1.1 Physical and Chemical Barriers
The outermost layer of innate immunity consists of structural and chemical defenses that prevent
the entry of pathogens. The skin, with its tightly packed keratinized epithelial cells and lipid-based
secretions, serves as a primary physical barrier. These secretions help create an acidic environment
that inhibits microbial growth. Mucosal surfaces, such as those lining the respiratory, gastrointestinal, and urogenital tracts, produce mucus that traps pathogens, while ciliated epithelial cells facilitate their removal. Chemical defenses, including lysozyme in tears and saliva, and antimicrobial
peptides like defensins, further inhibit microbial invasion. In the gastrointestinal tract, gastric acid
contributes to microbial neutralization. Together, these physical and chemical barriers form the rst
and often most effective line of immune defense.
1.2.1.2 Cellular Components of Innate Immunity
When pathogens breach the body’s physical and chemical defenses, a diverse set of innate immune
cells is rapidly activated to eliminate the threat. Among the earliest responders are granulocytes,
including neutrophils, eosinophils, and basophils. Neutrophils, the most abundant circulating
white blood cells, rapidly migrate to sites of infection where they engulf and destroy pathogens
using phagocytosis, reactive oxygen species, and antimicrobial enzymes. Eosinophils specialize in
defense against large extracellular parasites and contribute to allergic inammation, while basophils support immune responses through the release of histamine and cytokines.
Mononuclear phagocytes (macrophages and DCs) form a second line of defense. Macrophages
differentiate from blood monocytes and are involved in pathogen clearance, cytokine production,
and tissue repair. They can adopt different activation states, depending on the signals present in the
local environment. DCs serve as key antigen-presenting cells (APCs) that link innate and adaptive
immunity by capturing antigens in tissues and presenting them to T cells in lymphoid organs.
Mast cells, located primarily in mucosal and perivascular tissues, contribute to inammation
and host defense through the release of histamine, proteases, and cytokines in response to allergens
or microbial stimuli. Natural killer (NK) cells are cytotoxic lymphocytes that detect and eliminate
virus-infected and transformed cells without prior sensitization. By recognizing changes in surface
3 Immune Mechanisms and Major Autoimmune Diseases
FIGURE 1.2 The complement system.
markers, such as reduced MHC class I expression, NK cells induce apoptosis via perforin and granzymes and secrete interferon-gamma to modulate immune responses. Although lacking antigenspecic receptors, NK cells function at the interface of innate and adaptive immunity.
1.2.1.3 Soluble Molecular Components—The Complement System
In addition to its cellular elements, the innate immune system employs a range of soluble mediators, with the complement system being one of the most prominent. This system consists of over
30 plasma proteins that remain inactive until triggered by the presence of pathogens. Complement
activation proceeds via three pathways (the classical, lectin, and alternative pathways), all of which
converge on the cleavage of C3, producing fragments that promote pathogen opsonization, inammation, and cell lysis. One key product, C3b, tags pathogens for phagocytosis, while C3a and C5a
act as chemoattractants that enhance immune cell recruitment. The terminal stage involves the formation of the membrane attack complex (MAC), which disrupts microbial membranes and causes
lysis. Figure 1.2 illustrates the three pathways for activating the complement system.
The complement system not only reinforces innate immunity but also supports adaptive
responses. It enhances phagocytosis, stimulates inammation, and directly lyses certain pathogens.
Because of its potent activity, complement is tightly regulated by host proteins such as factor H,
CD55, and CD59 to prevent damage to self-tissues. Dysregulation of this system has been linked to
various inammatory and autoimmune conditions, highlighting its essential role in immune defense
and homeostasis.
1.2.1.4 Pattern Recognition and Activation
A hallmark of the innate immune system is its ability to detect invading pathogens and cellular
damage through germline-encoded PRRs. These receptors identify pathogen-associated molecular patterns (PAMPs), such as bacterial lipopolysaccharide and viral RNA, as well as damageassociated molecular patterns (DAMPs) released from injured host cells. PRRs are expressed by
various innate immune cells and are grouped into several major families, including TLRs, NLRs,
RIG-I-like receptors (RLRs), and C-type lectin receptors (CLRs). Their strategic distribution on the
cell surface, in endosomes, and within the cytoplasm enables surveillance of both extracellular and
intracellular compartments.
Upon ligand engagement, PRRs activate signaling cascades that lead to the expression of inammatory cytokines, chemokines, and type I interferons via transcription factors such as NF-κB and
IRFs. This rapid molecular response promotes inammation, initiates antimicrobial defense, and
shapes the adaptive immune response. For example, inammasome complexes formed by NLRs can
activate caspase-1, which processes pro-inammatory cytokines into their active forms. Through
these mechanisms, PRRs act as critical sensors that coordinate innate immune activation and link
it to downstream immune pathways.
Соседние файлы в папке Библиотека им академика М.И. Перельмана